Vish Sridharan, MD

Vish Sridharan is a Research Analyst on the Health Care Sector Research Team at Janus Henderson Investors, a position he has held since 2022. In this role, he is focused on biotechnology companies. Before joining the firm, Vish was in practice at Massachusetts General Hospital, where he also consulted for investment management firms on science-intensive or clinical opportunities. Additionally, Vish has worked with numerous biotechnology, capital management and pharmaceutical firms while earning multiple professional degrees and performing research at the Dana Farber Cancer Center and Brigham and Women’s Hospital.

Vish received a bachelor of science degree (Hons) in chemistry from University of North Carolina, graduating Phi Beta Kappa and an MBA from Harvard Business School. He also earned a doctor of medicine degree from the Harvard-MIT Program in Health Science and Technology, graduating with honours. He is board-certified in Internal Medicine and continues to see hospitalised patients in an ad-hoc capacity. He has 5 years of financial industry experience.